Drug companies are pushing combination medicines as a way to find new profits, cut down on generic competition and help patients reduce the number of pills they have to take and therefore buy fewer prescriptions. While critics complain the trend is little more than repackaging older products that otherwise would be overtaken by generic competition, one expert said doctors are accepting the "two-in-one" pill idea as long as it remains simple and patient-friendly.

Full Story:

Related Summaries